BCAX – bicara therapeutics inc. (US:NASDAQ)
Stock Stats
News
Bicara Therapeutics (NASDAQ:BCAX) is now covered by analysts at Citizens Jmp. They set a "market perform" rating and a $31.00 price target on the stock.
Bicara Therapeutics (NASDAQ:BCAX) is now covered by analysts at Citigroup Inc.. They set an "outperform" rating on the stock.
Bicara Therapeutics (NASDAQ:BCAX) had its "buy" rating reaffirmed by analysts at BTIG Research.
Bicara Therapeutics (NASDAQ:BCAX) had its "buy" rating reaffirmed by analysts at HC Wainwright.
Bicara Therapeutics (NASDAQ:BCAX) had its "buy" rating reaffirmed by analysts at UBS Group AG.
Form 4 Bicara Therapeutics Inc. For: Jan 22 Filed by: Cohlhepp Ryan
Form 4 Bicara Therapeutics Inc. For: Jan 22 Filed by: Hyep Ivan
Form 144 Bicara Therapeutics Inc. Filed by: Cohlhepp Ryan
Form 144 Bicara Therapeutics Inc. Filed by: Hyep Ivan
Form 4 Bicara Therapeutics Inc. For: Jan 15 Filed by: Cohlhepp Ryan
Top News Gainers
Top News Decliners
Live Event: How Top Hedge Funds Use News To Make Money From The Stock Market & How Ordinary People Are Copying Their Strategies
If you could use the news to make money from the stock market, would you? Join us on our live online event where you’ll discover this simple scientific method that has allowed ordinary people get a huge return from the stock market without excessive risk.